Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svane

Showing results (591-600 of 811) with videos related to

Pageof 82
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in MelanomaArianna Draghi, Mario Presti, Agnete W P Jensen, et al.
Nature Communications|November 25, 2017
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanomaMartin Lauss, Marco Donia, Katja Harbst, et al.
Cancers|March 6, 2021
Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa StudyNicolai Grønne Jørgensen, Jeanette Kaae, Jacob Handlos Grauslund, et al.
Scandinavian Journal of Work, Environment & Health|November 9, 2004
Cancer incidence of Nordic asphalt workersBritt Grethe Randem, Igor Burstyn, Sverre Langård, et al.
Nature Communications|April 3, 2020
Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanomaMartin Lauss, Marco Donia, Katja Harbst, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2024
Immune-related adverse events in a nationwide cohort of real-world melanoma patients treated with adjuvant anti-PD1 - Seasonal variation and association with outcomeRebecca Schou Jurlander, Louise Mahncke Guldbrandt, Rikke B Holmstroem, et al.
Oncoimmunology|February 6, 2018
Frequent adaptive immune responses against arginase-1Evelina Martinenaite, Rasmus Erik Johansson Mortensen, Morten Hansen, et al.
The Journal of Chemical Physics|March 16, 2015
Selection of conformational states in self-assembled surface structures formed from an oligo(naphthylene-ethynylene) 3-bit binary switchY Ning, J R Cramer, A Nuermaimaiti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 12, 2025
Evaluation of the pharmacological cathepsin S inhibitor LY3000328 on autoimmune diabetes in miceCaroline Frørup, Cecilie A B Svane, Mathias Høj Jensen, et al.
Journal of Science and Medicine in Sport|July 23, 2025
The potential diagnostic benefit of repeated troponin I measurements following high-intensity exerciseI H Hove, Ø Kleiven, M F Bjørkavoll-Bergseth, et al.
Pageof 82

Showing results (591-600 of 811) with videos related to

Sort By:
Pageof 82
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in MelanomaArianna Draghi, Mario Presti, Agnete W P Jensen, et al.
Nature Communications|November 25, 2017
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanomaMartin Lauss, Marco Donia, Katja Harbst, et al.
Cancers|March 6, 2021
Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa StudyNicolai Grønne Jørgensen, Jeanette Kaae, Jacob Handlos Grauslund, et al.
Scandinavian Journal of Work, Environment & Health|November 9, 2004
Cancer incidence of Nordic asphalt workersBritt Grethe Randem, Igor Burstyn, Sverre Langård, et al.
Nature Communications|April 3, 2020
Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanomaMartin Lauss, Marco Donia, Katja Harbst, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2024
Immune-related adverse events in a nationwide cohort of real-world melanoma patients treated with adjuvant anti-PD1 - Seasonal variation and association with outcomeRebecca Schou Jurlander, Louise Mahncke Guldbrandt, Rikke B Holmstroem, et al.
Oncoimmunology|February 6, 2018
Frequent adaptive immune responses against arginase-1Evelina Martinenaite, Rasmus Erik Johansson Mortensen, Morten Hansen, et al.
The Journal of Chemical Physics|March 16, 2015
Selection of conformational states in self-assembled surface structures formed from an oligo(naphthylene-ethynylene) 3-bit binary switchY Ning, J R Cramer, A Nuermaimaiti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 12, 2025
Evaluation of the pharmacological cathepsin S inhibitor LY3000328 on autoimmune diabetes in miceCaroline Frørup, Cecilie A B Svane, Mathias Høj Jensen, et al.
Journal of Science and Medicine in Sport|July 23, 2025
The potential diagnostic benefit of repeated troponin I measurements following high-intensity exerciseI H Hove, Ø Kleiven, M F Bjørkavoll-Bergseth, et al.
Pageof 82